These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16232019)

  • 1. Safety of outpatient dalteparin therapy in veterans with mechanical heart valves.
    O'Neill JL; Flanagan PS; Zaleon CR; Copeland LA
    Pharmacotherapy; 2005 Nov; 25(11):1560-5. PubMed ID: 16232019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.
    Dentali F; Riva N; Malato A; Saccullo G; Siragusa S; Ageno W
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):91-3. PubMed ID: 19154909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
    Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
    Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Our inability to predict thromboembolic events after prosthetic valve surgery.
    Will MB; Bernacca GM; Bell EF; Tolland MM; Lowe GD; Rumley A; Murray HM; Ford I; Wheatley DJ
    J Heart Valve Dis; 2006 Jul; 15(4):570-80; discussion 580. PubMed ID: 16901057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melagatran for thromboprophylaxis after mechanical valve implantation: results in a heterotopic porcine model.
    Thompson JL; Hamner CE; Potter DD; Lewin M; Sundt TM; Schaff HV
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):359-65. PubMed ID: 17662773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International normalized ratio patient self-management for mechanical valves: is it safe enough?
    Koerfer R; Reiss N; Koertke H
    Curr Opin Cardiol; 2009 Mar; 24(2):130-5. PubMed ID: 19532098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancies in identification of major bleeding events in patients taking warfarin.
    Seto AC; Kenyon K; Wittkowsky AK
    Pharmacotherapy; 2008 Sep; 28(9):1098-103. PubMed ID: 18752380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.
    Stassano P; Di Tommaso L; Monaco M; Iorio F; Pepino P; Spampinato N; Vosa C
    J Am Coll Cardiol; 2009 Nov; 54(20):1862-8. PubMed ID: 19892237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic.
    Hastings SN; Sloane RJ; Goldberg KC; Oddone EZ; Schmader KE
    J Am Geriatr Soc; 2007 Sep; 55(9):1339-48. PubMed ID: 17767675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.